• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    AC Immune S.A. (NQ: ACIU )

    2.440 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, May 2, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 2.440
    Bid (Size) 2.180 (1)
    Ask (Size) 2.650 (1)
    Prev. Close 2.440
    Today's Range 2.440 - 2.440
    52wk Range 1.780 - 5.140
    Shares Outstanding N/A
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    ACIU Stock Earnings: AC Immune Beats EPS, Beats Revenue for Q4 2023
    ACIU stock results show that AC Immune beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023. 
    Via InvestorPlace
    AC Immune Reports Full Year 2023 Financial Results and Provides a Corporate Update
    From AC Immune SA
    Via GlobeNewswire

    Performance

    YTD
    -47.97%
    -47.97%
    1 Month
    -9.63%
    -9.63%
    3 Month
    -23.27%
    -23.27%
    6 Month
    -13.78%
    -13.78%
    1 Year
    +31.89%
    +31.89%

    More News

    Read More
    AC Immune Announces Upcoming Presentations at AD/PD™ 2024
    From AC Immune SA
    Via GlobeNewswire
    AC Immune to Regain Global Rights to Crenezumab and Semorinemab
    From AC Immune SA
    Via GlobeNewswire
    AC Immune Progress Update on Phase 2 Active Immunotherapy Clinical Pipeline for Alzheimer's and Parkinson diseases
    From AC Immune SA
    Via GlobeNewswire
    Why Shares of AC Immune Jumped This Week
    Via The Motley Fool
    Why AC Immune Stock Skyrocketed Today
    Via Benzinga
    AC Immune Raises $50M, Its Alzheimer's Targeting Immunotherapy Advances Into Phase 2b Trial
    Via Benzinga
    AC Immune Announces Pricing of Underwritten Offering of Common Shares
    From AC Immune SA
    Via GlobeNewswire
    AC Immune’s Targeted Anti-pTau Active Immunotherapy for Alzheimer’s Disease Advances into Phase 2b Trial
    From AC Immune SA
    Via GlobeNewswire
    AC Immune Strengthens Management, Appoints Madiha Derouazi as CSO and Christopher Roberts as CFO
    From AC Immune SA
    Via GlobeNewswire
    Penny Stock Powerhouses: 7 Picks Poised for Explosive Growth
    Via InvestorPlace
    Alzheimer's Disease Vaccines: Promising Developments, Renewed Enthusiasm From Biogen, Eli Lilly And Others
    Via Benzinga
    AC Immune to Present at the Jefferies 2023 London Healthcare Conference
    From AC Immune SA
    Via GlobeNewswire
    AC Immune Reports Third Quarter 2023 Financial Results and Provides a Corporate Update
    From AC Immune SA
    Via GlobeNewswire
    AC Immune to Host KOL Webinar on Amyloid Plaque PET Imaging in Alzheimer’s Disease as a Surrogate of Clinical Efficacy on November 9, 2023
    From AC Immune SA
    Via GlobeNewswire
    AC Immune Clinical Data Published in Nature Communications Show Alpha-Synuclein PET Tracer ACI-12589 Has Potential as Neurodegenerative Disease Diagnostic
    From AC Immune SA
    Via GlobeNewswire
    AC Immune Announces Upcoming Presentations at the 16th CTAD Conference
    From AC Immune SA
    Via GlobeNewswire
    AC Immune to Present at the Jefferies 2023 CNS & Neuro Summit in October 2023
    From AC Immune SA
    Via GlobeNewswire
    AC Immune to Present at the H.C. Wainwright 25th Annual Global Investment Conference in September 2023
    From AC Immune SA
    Via GlobeNewswire
    AC Immune Reports Second Quarter 2023 Financial Results and Provides a Corporate Update
    From AC Immune SA
    Via GlobeNewswire
    AC Immune to Present at the BTIG Virtual Biotechnology Conference 2023
    From AC Immune SA
    Via GlobeNewswire
    AC Immune SA Appoints New Chief Medical Officer
    From AC Immune SA
    Via GlobeNewswire
    AC Immune Showcasing Precision Medicine Programs at AAIC 2023
    From AC Immune SA
    Via GlobeNewswire
    Why Walgreens Shares Are Trading Lower By Over 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.